Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company's United States subsidiary, Medicure Pharma Inc. It also operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medication for all Americans together with exceptional customer service and free home delivery. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It also develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, compositions containing P5P Analogues.

TSXV:MPH - Post by User

Medicure Inc > Will this be just another Bert Friesen Failure?

<< Previous

Bullboard Posts

Next >>

Comment by pholoveron Sep 22, 2024 12:33am

150 Views

Post# 36235126

RE:RE:Will this be just another Bert Friesen Failure?

Very insightful post Whalewatcher. I have heard that it has been brought to the attention of more than one Director. Self dealing/filing patents using a related Company in this case is utterly shameful and shows the lack of character with Friesen who has a Rolls Royce while he has lost tens of millions of dollars for his shareholders, takes a salary that is 75% of the CEO salary for the Exchange Group, a Company that has made their shareholders hundreds of millions of dollars and worse, he spreads his time around so many related entities that all strip funds from Medicure

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario